pubmed-article:7288173 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C0029341 | lld:lifeskim |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C0205419 | lld:lifeskim |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C1707391 | lld:lifeskim |
pubmed-article:7288173 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:7288173 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:7288173 | pubmed:dateCreated | 1981-12-15 | lld:pubmed |
pubmed-article:7288173 | pubmed:abstractText | Antigenic variants of A/Texas/77 (H3N2) virus were selected in vitro using monoclonal antibody to virus haemagglutinin (HA). The antigenic variants and parental A/Texas/77 viruses were used to to evaluate the frequency of anti-HA antibodies in the sera of children and adults using single-radial-haemolysis (SRH) tests. Twenty to 41% of selected sera from adults, which contained antibody to the parental A/Texas/77 virus, failed to react with the different antigenic mutant viruses. A higher proportion of sera from children (37-58%) failed to react with the antigenic variants. Certain human sera and particularly those of children would appear to possess a more limited antibody repertoire to influenza HA, potentially allowing new antigenic variants to escape neutralization and spread in the community. | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:language | eng | lld:pubmed |
pubmed-article:7288173 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7288173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7288173 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7288173 | pubmed:month | Oct | lld:pubmed |
pubmed-article:7288173 | pubmed:issn | 0022-1724 | lld:pubmed |
pubmed-article:7288173 | pubmed:author | pubmed-author:SchildG CGC | lld:pubmed |
pubmed-article:7288173 | pubmed:author | pubmed-author:OxfordJ SJS | lld:pubmed |
pubmed-article:7288173 | pubmed:author | pubmed-author:NataliAA | lld:pubmed |
pubmed-article:7288173 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7288173 | pubmed:volume | 87 | lld:pubmed |
pubmed-article:7288173 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7288173 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7288173 | pubmed:pagination | 185-90 | lld:pubmed |
pubmed-article:7288173 | pubmed:dateRevised | 2010-9-10 | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:meshHeading | pubmed-meshheading:7288173-... | lld:pubmed |
pubmed-article:7288173 | pubmed:year | 1981 | lld:pubmed |
pubmed-article:7288173 | pubmed:articleTitle | Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody. | lld:pubmed |
pubmed-article:7288173 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7288173 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7288173 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7288173 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7288173 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7288173 | lld:pubmed |